Seeking Alpha
 

Sequenom, Inc. (SQNM)

- NASDAQ
  • Jul. 6, 2012, 9:10 AM
    Premarket gainers: BOOT +81%. PCX +10%. JRCC +6%.
    Losers: INFA -30%. ALXA -11%. APKT -10%. AONE -8%. SQNM -6%.
    | Jul. 6, 2012, 9:10 AM | Comment!
  • May 17, 2012, 5:24 PM
    Sequenom (SQNM) says the recently announced provider network participation agreement with Coventry Health Care (CVH) has been terminated without cause by Coventry. The agreement was intended to provide members in the network with coverage for Sequenom CMM's MaterniT21 PLUS laboratory-developed test. SQNM -7.8% AH.
    | May 17, 2012, 5:24 PM | Comment!
  • May 9, 2012, 4:54 PM
    The big move higher in Zillow (Z) over the past 2 weeks takes on a bit more interest with the disclosure Stevie Cohen's SAC Capital has accumulated a 5% stake in the company. The hedge fund has also increased positions or taken new stakes in Sequenom (SQNM), Western Refining (WNR), YELP, and Walter Energy (WLT), among others.
    | May 9, 2012, 4:54 PM | 1 Comment
  • May 3, 2012, 8:29 PM
    Sequenom (SQNM): Q1 EPS of -$0.22 misses by $0.03. Revenue of $14.9M (+10.4% Y/Y) misses by $1.4M. Shares -3% AH. (PR)
    | May 3, 2012, 8:29 PM | Comment!
  • Apr. 24, 2012, 5:46 PM
    Sequenom (SQNM) surged 9.4% today after a Wedbush analyst said results for its Maternit21 fetal genetic tests make it harder to argue that investors should short the stock. “SQNM has effectively met development and commercial launch milestones in the last 12 months and has driven significant test volume in the first six months of launch," the firm says.
    | Apr. 24, 2012, 5:46 PM | Comment!
  • Apr. 19, 2012, 10:29 AM
    Shares of Sequenom (SQNM +6.9%) jump higher in early trading after the firm announces an expanded agreement with healthcare cost management firm Provider Multiplan to include the MaterniT21 fetal test at more than 900 providers in its network. The frothy bid for Human Genome is also adding to the bullish sentiment over Sequenom - viewed as a juicy takeover candidate itself.
    | Apr. 19, 2012, 10:29 AM | Comment!
  • Apr. 16, 2012, 11:34 AM
    Shares of Sequenom (SQNM +9.5%) pop after the firm raises its estimate for billings for MaterniT21 in 2012 to 40K from a previous forecast of 25K. The firm says it will increase internal production goals based on the improved outlook.
    | Apr. 16, 2012, 11:34 AM | Comment!
  • Apr. 16, 2012, 9:05 AM
    Premarket gainers: ECYT +114%. DRJ +30%. CSIQ +9%. SQNM +9%. LDK +7%. TSL +6%. RENN +4%. YGE +4%. STX +4%. JASO +4%. STP +4%. ANR +3%.
    Losers: PCO -47%. HALO -22%. SANG -5%. BAX -4%. MAT -4%. RBS -3%. VALE -3%.
    | Apr. 16, 2012, 9:05 AM | Comment!
  • Mar. 8, 2012, 9:00 AM
    Premarket gainers: MWA +18%. XOMA +8%. SQNM +7%. NBG +5%. GNOM +4%. CCI +4%. RAD +5%. MWW +4%. DB +4%. ING +4%. RIO +3%. MT +3%. BUD +3%. DRYS +3%. ARMH +3%. STO +3%. UBS +3%. SINA +3%. AEO +3%.
    Losers: DNDN -13%. STP -6%. ALKS -5%. WSM -4%. AMLN -4%. MCD -3%. CIGX -3%. UAL -3%. AGNC -3%.
    | Mar. 8, 2012, 9:00 AM | 2 Comments
  • Mar. 7, 2012, 4:47 PM
    Sequenom (SQNM): Q4 EPS of -$0.22 misses by $0.04. Revenue of $15.5M (+12.3% Y/Y) in-line. Shares +6.3% AH. (PR)
    | Mar. 7, 2012, 4:47 PM | Comment!
  • Feb. 21, 2012, 11:26 AM
    Time Magazine is slated to print a feature in its Feb. 27th edition that profiles the possible benefits of Sequenom's (SQNM +0.2%) new product for testing a prenatal baby's DNA for Down syndrome. (sneak peek .pdf)
    | Feb. 21, 2012, 11:26 AM | Comment!
  • Jan. 25, 2012, 10:02 AM
    The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB, GNOM, LIFE) on M&A speculation - as Sequenom (SQNM +2.2%), Qiagen (QGEN +1.5%), and Luminex (LMNX +1.1%) all catch bids in early trading.
    | Jan. 25, 2012, 10:02 AM | Comment!
  • Jan. 20, 2012, 10:57 AM
    Sequenom (SQNM -3.5%) bounces back a bit after being down over 8% just prior to the opening bell, in reaction to the company's pricing of its 13M share offering at $4.15 - a 10% discount to yesterday's close.
    | Jan. 20, 2012, 10:57 AM | Comment!
  • Jan. 20, 2012, 9:15 AM
    Premarket gainers: INSM +24%. ASIA +16%. SWKS +6%. URRE +6%. MPC +5%. BCS +4%. CTIC +4%. RBS +3%. IBM +3%. SAVE +3%. MSFT +3%.
    Losers: ALTH -20%. GOOG -8%. AONE -7%. SQNM -6%. HTGC -6%. COF -6%. PH -5%. ZIOP -5%. MMLP -5%. BWP -4%. CX -4%. CUK -4%. ARCC -4%. CCL -3%. NVS -3%. MT -3%.
    | Jan. 20, 2012, 9:15 AM | Comment!
  • Jan. 19, 2012, 4:11 PM
    Shares of Sequenom (SQNM) fall 7.8% AH after the firm announces that it plans to sell shares in an underwritten public offering without specifying an amount or a time period.
    | Jan. 19, 2012, 4:11 PM | Comment!
  • Dec. 19, 2011, 9:10 AM
    Premarket gainers: WINN +72%. SQNM +7%. AMR +5%. TTM +4%. CVC +4%. CPST +3%.
    Losers: MAS -6%. SCHN -6%. EGO -6%. LPL -6%. SNV -4%. LYG -3%.
    | Dec. 19, 2011, 9:10 AM | Comment!
Visit Seeking Alpha's
SQNM vs. ETF Alternatives
Company Description
Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services.
Sector: Healthcare
Industry: Biotechnology
Country: United States